van Onna, Marloes Öztürk, Betül Starmans, Mirian Peeters, Ralph Boonen, Annelies
Published in
Clinical Rheumatology
To explore in elderly patients with rheumatoid arthritis (RA) and comorbidity (1) in which order and why patients prioritize their morbidities with regard to functioning and health, (2) their beliefs about common (age-related) musculoskeletal complaints, and (3) experiences about the influence of comorbidity on medication treatment of RA. Patients ...
Maghsoudi, Hossein Hallajzadeh, Jamal Rezaeipour, Mozhghan
Published in
Clinical Rheumatology
Osteoarthritis (OA) is a chronic degenerative joint disease with inflammatory component. It is associated with progressive histological alterations and disabling symptoms. Today, drugs such as glucocorticoids (GCs) and nonsteroidal anti-inflammatory drugs (NSIADs) are commonly employed for treatment of osteoarthritis, but have serious and life-thre...
Dang, Wantai Xu, Dan Xie, Wenguang Zhou, Jingguo
Published in
Clinical Rheumatology
It is well-known that NLRP3 is closely related to the onset of primary gout (PG). However, the relation between NLRP3 gene transcript variants and the occurrence of PG remains unclear. This study was undertaken to evaluate whether NLRP3 gene transcript variants are involved in the occurrence of PG. A total of 44 acute phase PG (APPG), 52 non-acute ...
Zhou, Haiyan Hu, Bailong Huang, Niwen Mo, Xiangang Li, Wei Zhang, Bei Wei, Bo Gao, Mingzhu Wang, Yiming Liu, Xingde
...
Published in
Clinical Rheumatology
To assess T cell subsets and levels of chemokines and cytokines in patients with SLE and determine their relationships between disease activity and organ involvement. Blood samples from SLE patients (n = 24) and healthy controls (n = 36) were analyzed. Frequency of circulating follicular help T cells (Tfh), central memory T cells (Tcm), effector me...
Wah-Suarez, Martin I. Galarza-Delgado, Dionicio A. Azpiri-Lopez, Jose R. Colunga-Pedraza, Iris J. Cardenas-de la Garza, Jesus Alberto Vera-Pineda, Raymundo Arvizu-Rivera, Rosa I. Martinez-Moreno, Adrian Ramos-Cazares, Ray E. Abundis-Marquez, Elizabeth E.
...
Published in
Clinical Rheumatology
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in patients with rheumatoid arthritis (RA). Chronic inflammation and traditional risk factors increase cardiovascular risk (CVR) in these patients. Several CVR calculators are used in general population and in RA patients to predict cardiovascular outcomes and tailor thera...
Greco, Martín Rúa-Figueroa, Íñigo Ghiglione, Sabrina Santana Medina, Efrén Quevedo Abeledo, Juan Carlos Rodríguez-Lozano, Carlos
Published in
Clinical Rheumatology
The presentation of the Table 1 of the original version of this article was incorrectly published. The Table is now presented correctly in this article.
Scrivo, Rossana Gerardi, Maria Chiara Rutigliano, Iolanda Sessa, Paola Mipatrini, Daniele Stricchiola, Gaetana Maria Grazia Pacella, Elena Altobelli, Alessio Castellani, Chiara Alessandri, Cristiano
...
Published in
Clinical Rheumatology
In a previous report of two married cohabiting couples affected by polymyalgia rheumatica (PMR), we noticed that the wife of one couple and both members of the other couple suffered from symptomatic diverticular disease (DD), whose diagnosis was made before the onset of PMR. We investigated whether DD might be a risk factor for the development of P...
Pappas, Dimitrios A. Nyberg, Fredrik Kremer, Joel M. Lampl, Kathy Reed, George W. Horne, Laura Ho, Meilien Onofrei, Alina Malaviya, Anand N. Rillo, Oscar L.
...
Published in
Clinical Rheumatology
To compare the prevalence of cardiovascular disease (CVD) and major CVD risk factors among rheumatoid arthritis (RA) patients enrolled in a large US and multinational registry. We compared CVD and CVD risk factor prevalence from 11 countries enrolled in the CORRONA US and CORRONA International registries; patients from the 10 ex-US participating co...
Royle, Jeremy G. Lanyon, Peter C. Grainge, Matthew J. Abhishek, Abhishek Pearce, Fiona A.
Published in
Clinical Rheumatology
The above article originally published with an error present in the 2nd sentence in the 4th paragraph of the discussion section and is now presented correctly in this article. The remainder of the article remains unchanged.
Zekovic, Ana Vreca, Misa Spasovski, Vesna Andjelkovic, Marina Pavlovic, Sonja Damjanov, Nemanja
Published in
Clinical Rheumatology
Genetic predisposition to systemic sclerosis (SSc) has still not been fully revealed. Interleukin-6 (IL-6) is a mediator of T cell proliferation and fibrotic events in SSc. Polymorphisms in the IL-6 are found to be important in susceptibility to development of SSc. We aimed to assess the frequency of -174 C/G of IL-6 gene polymorphism in SSc patien...
